412 related articles for article (PubMed ID: 28353057)
21. An initial experience with therapeutic drug monitoring of levetiracetam as reported from a pediatric clinical setting in India.
Mathew BS; Fleming DH; Thomas M; Prabha R; Saravanakumar K
Neurol India; 2012; 60(2):146-9. PubMed ID: 22626693
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic drug monitoring of levetiracetam].
Dailly E; Bouquié R; Bentué-Ferrer D;
Therapie; 2010; 65(1):67-70. PubMed ID: 20205999
[TBL] [Abstract][Full Text] [Related]
23. [Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties].
Wagner GL; Wilms EB; Vecht ChJ
Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1218-21. PubMed ID: 12132136
[TBL] [Abstract][Full Text] [Related]
24. Levetiracetam in pediatrics.
Vigevano F
J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
[TBL] [Abstract][Full Text] [Related]
25. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation.
Perucca E; Dulac O; Shorvon S; Tomson T
CNS Drugs; 2001; 15(8):609-21. PubMed ID: 11524033
[TBL] [Abstract][Full Text] [Related]
26. Antiepileptic Drugs.
Abou-Khalil BW
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):132-56. PubMed ID: 26844734
[TBL] [Abstract][Full Text] [Related]
27. Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.
Leppik IE
J Child Neurol; 2002 Jan; 17 Suppl 1():S53-7. PubMed ID: 11918464
[TBL] [Abstract][Full Text] [Related]
28. Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review.
Weijenberg A; Brouwer OF; Callenbach PM
CNS Drugs; 2015 May; 29(5):371-82. PubMed ID: 26013703
[TBL] [Abstract][Full Text] [Related]
29. Preliminary efficacy of levetiracetam in monotherapy.
Ben-Menachem E
Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Drug Monitoring of Levetiracetam in Select Populations.
Jarvie D; Mahmoud SH
J Pharm Pharm Sci; 2018; 21(1s):149s-176s. PubMed ID: 30096051
[TBL] [Abstract][Full Text] [Related]
31. Safety profile of levetiracetam.
Arroyo S; Crawford P
Epileptic Disord; 2003 May; 5 Suppl 1():S57-63. PubMed ID: 12915343
[TBL] [Abstract][Full Text] [Related]
32. Saliva and serum levetiracetam concentrations in patients with epilepsy.
Mecarelli O; Li Voti P; Pro S; Romolo FS; Rotolo M; Pulitano P; Accornero N; Vanacore N
Ther Drug Monit; 2007 Jun; 29(3):313-8. PubMed ID: 17529888
[TBL] [Abstract][Full Text] [Related]
33. New antiepileptic drugs in pediatric epilepsy.
Hwang H; Kim KJ
Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam in refractory pediatric epilepsy.
Wheless JW; Ng YT
J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
[TBL] [Abstract][Full Text] [Related]
35. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs.
Jacob S; Nair AB
Drugs R D; 2016 Dec; 16(4):303-316. PubMed ID: 27766590
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
[TBL] [Abstract][Full Text] [Related]
37. Levetiracetam in childhood epilepsy.
Verrotti A; D'Adamo E; Parisi P; Chiarelli F; Curatolo P
Paediatr Drugs; 2010 Jun; 12(3):177-86. PubMed ID: 20486734
[TBL] [Abstract][Full Text] [Related]
38. The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
Perucca E; Johannessen SI
Epileptic Disord; 2003 May; 5 Suppl 1():S17-26. PubMed ID: 12915337
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics of levetiracetam.
Patsalos PN
Clin Pharmacokinet; 2004; 43(11):707-24. PubMed ID: 15301575
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Plasma, Saliva, and Hair Levetiracetam Concentrations.
Karaś-Ruszczyk K; Kuczyńska J; Sienkiewicz-Jarosz H; Kurkowska-Jastrzębska I; Bienkowski P; Restel M; Samochowiec J; Mierzejewski P
Ther Drug Monit; 2017 Jun; 39(3):263-268. PubMed ID: 28490049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
